氨基-(4-羟基-3-甲氧基-苯基)-乙酸 | 56246-88-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 氨基-(4-羟基-3-甲氧基-苯基)-乙酸
• 英文名称: 2-(3'-Methoxy-4'-hydroxyphenyl)-glycin
• 英文别名: 2-azaniumyl-2-(4-hydroxy-3-methoxyphenyl)acetate
• CAS: 56246-88-9
• 化学式: C₉H₁₁NO₄
• mdl: MFCD02662545
• 分子量: 197.191
• InChiKey: FHICNDDORUKGPD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.7
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  92.8
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  氨基-(4-羟基-3-甲氧基-苯基)-乙酸 在 盐酸 作用下， 以 甲醇 、 水 为溶剂， 生成 methyl 2-(3'-methoxy-4'-hydroxyphenyl)glycinate
  参考文献：
  名称：

  Derivatives of 7-(cyclized)phenylglycyl-3-triazolo-thio methyl

  摘要：

  式为##STR1##的化合物，其中A为氢、羟基、甲基或甲氧基，R.sup.1为氢、钠或钾，R.sup.2为1,2,3-三唑-5-基，该基团未取代或取代为一个或两个碳原子数为一至四的较低烷基基团，通过将适当的醛与相应的两性头孢菌素反应制备而成。首选产物具有结构##STR2##

  公开号：

  US04061862A1
• 作为产物：
  描述：

  氰化钾 、 香草醛 在 乙醚 、 ammonium chloride 、 水 作用下， 生成 氨基-(4-羟基-3-甲氧基-苯基)-乙酸
  参考文献：
  名称：

  Bloch, Hoppe-Seyler's Zeitschrift fur Physiologische Chemie, 1916, vol. 98, p. 239

  摘要：

  DOI：

文献信息

• Substituted vinyl cephalosporins
  申请人：Bristol-Myers Company

  公开号：US04520022A1

  公开（公告）日：1985-05-28

  3-[(Z)-1-Propen-1-yl]-7-acylamido cephalosporins in which the 7-acyl group is phenylglycyl or substituted phenylglycyl are orally active antibiotics against Gram+ and Gram- bacteria.

  3-[(Z)-1-丙烯基]-7-酰胺头孢菌素，其中7-酰基为苯甘氨基或取代苯甘氨基，是针对革兰氏阳性和阴性细菌的口服活性抗生素。
• [EN] BIPHENYL DERIVATIVES AS MODULATORS OF THE HISTAMINE-H3 RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO<br/>[FR] DÉRIVÉS DE BIPHÉNYLE COMME MODULATEURS DU RÉCEPTEUR H-3 DE L'HISTAMINE UTILES POUR LE TRAITEMENT DE TROUBLES SE RAPPORTANT À CELUI-CI
  申请人：ARENA PHARM INC

  公开号：WO2009058300A1

  公开（公告）日：2009-05-07

  Biphenyl derivatives of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the H3 histamine receptor. (Ia) Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of histamine H3-associated disorders, such as cognitive disorders, epilepsy, brain trauma, depression, obesity, disorders of sleep and wakefulness, such as narcolepsy, shift-work syndrome, drowsiness as a side effect from a medication, maintenance of vigilance to aid in completion of tasks and the like, cataplexy, hypersomnia, somnolence syndrome, jet lag, sleep apnea and the like, attention deficit hyperactivity disorder (ADHD), schizophrenia, allergies, allergic responses in the upper airway, allergic rhinitis, nasal congestion, dementia, Alzheimer's disease, pain and the like.

  式(Ia)联苯衍生物及其调节H3组胺受体活性的药用组合物。本发明化合物及其药用组合物针对治疗与组胺H3受体相关的一系列疾病的方法，包括认知障碍、癫痫、脑创伤、抑郁症、肥胖症、睡眠与觉醒障碍，如嗜睡症、轮班工作综合征、药物副作用引起的嗜睡、保持警觉以帮助完成任务等、猝倒症、过度嗜睡、嗜睡综合征、时差反应、睡眠呼吸暂停等；注意力缺陷多动障碍(ADHD)、精神分裂症、过敏反应、上呼吸道过敏、过敏性鼻炎、鼻塞、痴呆、阿尔茨海默病、疼痛等。
• Certain derivatives of particular 3-thiolated cephalosporins
  申请人：Bristol-Myers Company

  公开号：US04026888A1

  公开（公告）日：1977-05-31

  Compounds of the formula ##STR1## wherein A is hydrogen, hydroxy, methyl or methoxy, R.sup.1 is hydrogen, sodium or potassium, R.sup.2 is carboxyl or an aliphatic, aromatic or heterocyclic radical to which there is also attached a strongly acidic group in the form of its sodium or potassium salt, and R.sup.3 is 1,2,3-triazol-5-yl, such group being unsubstituted or substituted with one or two lower alkyl groups of one to four carbon atoms are prepared by reacting the appropriate aldehyde with the corresponding amphoteric cephalosporin. A preferred product has the structure ##STR2##

  化合物的公式为##STR1##其中A是氢，羟基，甲基或甲氧基，R.sup.1是氢，钠或钾，R.sup.2是羧基或脂肪，芳香或杂环基，其中也附有强酸性基团以其钠或钾盐的形式，而R.sup.3是1,2,3-三唑-5-基团，该基团未被取代或被一个或两个碳原子为一到四的低烷基取代，通过将适当的醛与相应的两性头孢菌素反应制备而成。一种优选的产物具有结构##STR2##
• Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure–activity relationship studies
  作者：Haofan Wang、Youngjoo Byun、Cyril Barinka、Mrudula Pullambhatla、Hyo-eun C. Bhang、James J. Fox、Jacek Lubkowski、Ronnie C. Mease、Martin G. Pomper

  DOI：10.1016/j.bmcl.2009.10.061

  日期：2010.1

  We report a strategy based on bioisosterism to improve the physicochemical properties of existing hydrophilic, urea-based GCPII inhibitors. Comprehensive structure-activity relationship studies of the P1' site of ZJ-43- and DCIBzL-based compounds identified several glutamate-free inhibitors with K-i values below 20 nM. Among them, compound 32d (K-i = 11 nM) exhibited selective uptake in GCPII-expressing tumors by SPECT-CT imaging in mice. A novel conformational change of amino acids in the S1' pharmacophore pocket was observed in the X-ray crystal structure of GCPII complexed with 32d. (C) 2009 Elsevier Ltd. All rights reserved.
• BIPHENYL DERIVATIVES AS MODULATORS OF THE HISTAMINE-H3 RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
  申请人：Arena Pharmaceuticals, Inc.

  公开号：EP2217592A1

  公开（公告）日：2010-08-18